These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 7582386

  • 21. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR, Pula KK, Alton KB, Burrier RE, Watkins RW.
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [Abstract] [Full Text] [Related]

  • 22. [Can hyperlipidemia after heart transplantation be optimally and safely treated?].
    Wenke K, Thiery J, Arndtz N, Seidel D, Reichart B.
    Helv Chir Acta; 1994 Dec; 60(6):1163-8. PubMed ID: 7875999
    [Abstract] [Full Text] [Related]

  • 23. [Treatment of dyslipidemia of the elderly with simvastatin and pravastatin. Effectiveness and tolerance].
    Panuccio D, Trabatti MR, Romani A.
    Clin Ter; 1994 May; 144(5):419-24. PubMed ID: 7924180
    [Abstract] [Full Text] [Related]

  • 24. [Effects of pravastatin on serum lipids, apoproteins, and lipoprotein (a) in primary hypercholesterolemia].
    Galetta F, Sampietro T, Basta G, Bionda A.
    Minerva Med; 1994 Jun; 85(6):321-6. PubMed ID: 8084435
    [Abstract] [Full Text] [Related]

  • 25. Cholesterol synthesis inhibitors do not reduce Lp(a) levels in normocholesterolemic patients.
    Pazzucconi F, Franceschini G, Gianfranceschi G, Campagnoli G, Sirtori CR.
    Pharmacol Res; 1996 Jun; 34(3-4):131-3. PubMed ID: 9051704
    [Abstract] [Full Text] [Related]

  • 26. [Effects of simvastatin on plasma lipoproteins].
    Alessandri C, Basili S, Maurelli M, Andreozzi P, Bracaglia D, Cordova C.
    Clin Ter; 1994 Jan; 144(1):3-9. PubMed ID: 8168349
    [Abstract] [Full Text] [Related]

  • 27. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 28. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia.
    Milani M, Cimminiello C, Lorena M, Arpaia G, Soncini M, Bonfardeci G.
    Biomed Pharmacother; 1996 Nov; 50(6-7):269-74. PubMed ID: 8952866
    [Abstract] [Full Text] [Related]

  • 29. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study].
    Pernigotti L, Bo M, Poli L, Zanocchi M, Fiandra U, Pedrazzini V, Fabris F.
    Recenti Prog Med; 1991 Mar; 82(3):155-62. PubMed ID: 2047557
    [Abstract] [Full Text] [Related]

  • 31. A review of clinical trials comparing HMG-CoA reductase inhibitors.
    Illingworth DR, Tobert JA.
    Clin Ther; 1994 Mar; 16(3):366-85; discussion 365. PubMed ID: 7923304
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of three statins at lower maintenance doses.
    Carr-Lopez S, Exstrum T, Morse T, Shepherd M, Bush AC.
    Clin Ther; 1999 Feb; 21(2):331-9. PubMed ID: 10211536
    [Abstract] [Full Text] [Related]

  • 33. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 34. Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin.
    De Vries AC, Vermeer MA, Bredman JJ, Bär PR, Cohen LH.
    Exp Eye Res; 1993 Apr; 56(4):393-9. PubMed ID: 8500554
    [Abstract] [Full Text] [Related]

  • 35. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H, Fager G.
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [Abstract] [Full Text] [Related]

  • 36. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
    Caruzzo C, Uslenghi E, Varbella F, Caruzzo E, Marcolongo M, Brusca A.
    Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857
    [Abstract] [Full Text] [Related]

  • 37. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I, Spinler SA, Johnson NE.
    Ann Pharmacother; 1995 Dec; 29(7-8):743-59. PubMed ID: 8520093
    [Abstract] [Full Text] [Related]

  • 38. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)].
    Golay A, Lehmann T, James R, Pometta D.
    Schweiz Med Wochenschr; 1993 Aug 21; 123(33):1553-8. PubMed ID: 8372340
    [Abstract] [Full Text] [Related]

  • 39. [Effect of a long-term treatment with simvastatin, an inhibitor of HMG-CoA reductase, in dyslipidemic patients at high risk].
    Strano A, Novo S, Notarbartolo A, Davì G, Abrignani MG, Alaimo G, Averna MR, Barbagallo CM, Marino G.
    Cardiologia; 1989 Dec 21; 34(12):1027-33. PubMed ID: 2634479
    [Abstract] [Full Text] [Related]

  • 40. Bezafibrate and simvastatin (MK-733) in the treatment of primary hypercholesterolaemia.
    Smith DH, Neutel JM, Jankelow D, Myburgh DP.
    S Afr Med J; 1990 May 19; 77(10):500-3. PubMed ID: 2188379
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.